IMX-150 Cream for Diabetic Neuropathy

• Status: Completed
• Trial end date: 2008-03-01

Summary

The purpose of this study is to compare the effectiveness of two different dose of IMX-150 to that of placebo (non-active) in the treatment of diabetic peripheral neuropathy pain of the feet.

• Phase: Phase 2

Details

• Lead Sponsor: Procris Pharmaceuticals